Document is current
Any future updates will be listed below
-
Authors
Agarwal, Rimjhim https://orcid.org/0000-0002-6939-5077
Ha, Calvin https://orcid.org/0009-0005-2028-886X
Côrtes, Fernanda H.
Lee, Yeji https://orcid.org/0000-0003-2175-0049
Martínez-Pérez, Amparo https://orcid.org/0000-0003-3898-5709
Gálvez, Rosa Isela https://orcid.org/0000-0002-9320-2570
Castillo, Izabella N. https://orcid.org/0009-0003-2815-2807
Phillips, Elizabeth J.
Mallal, Simon A.
Balmaseda, Angel
Harris, Eva https://orcid.org/0000-0002-7238-4037
Romero-Vivas, Claudia M.
Premkumar, Lakshmanane https://orcid.org/0000-0002-1736-1350
Falconar, Andrew K. https://orcid.org/0000-0002-2066-9487
Grifoni, Alba https://orcid.org/0000-0002-2209-5966
Sette, Alessandro https://orcid.org/0000-0001-7013-2250
Weiskopf, Daniela https://orcid.org/0000-0003-2968-7371
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 6 June 2025
First Online: 1 July 2025
Competing interests
: D.W is a consultant for Moderna. A.S. is a consultant for Alcimed, Arcturus, Darwin Health, Desna Therapeutics, EmerVax, Gilead Sciences, Guggenheim Securities, Link University and RiverVest Venture Partners. LJI has filed for patent protection for various aspects of T cell epitope and vaccine design work. The remaining authors declare no conflicts of interest.
